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Comparative Genomic Hybridization of Germ Cell 
Tumors of the Adult Testis: Confirmation of Karyotypic 
Findings and Identification of a 12p-Amplicon
M. M. C. Mostert, M. van de Pol, D. Olde Weghuis,
R. F. Suijkerbuijk, A. Geurts van Kessel, J. van Echten,
J. W. Oosterhuis, and L. H. J. Looijenga
ABSTRACT: Comparative genomic hybridization (CGH) was carried out on 15 primary testicular germ 
cell tumors (TGCT) o f adolescents and adults and two metastatic residual tumors after chemotherapeu­
tic treatment. The results were compared with karyotypic data obtained form the same tumor specimens 
after direct harvesting o f metaphases or short-term in vitro culture. .Both techniques revealed that the 
most consistent abnormality in primary TGCT is gain o f 12p-sequences. Although In m ost cases over­
representation o f the complete short arm was observed, CGH revealed a specific amplification of 
1 2 p ll.l-p l2 ,l  region in two independent primary tumors. In additiont loss of (parts of) chromosome 13 
(always involving q31-qter), and gain o f (parts of) chromosome 7 (mostly involving q ll) , (parts of) chro­
mosome 8, and the X  chromosome were detected in more than 25% o f the tumors by this latter tech­
nique. Loss of 6ql5-q21 in both residual tumors analyzed m ay suggest a role for this anomaly in 
acquired resistance to chemotherapeutic treatment
Overall, the CGH analyses confirmed gains and losses o f certain chromosomal regions in TGCT as 
observed by karyotyping, and thus support their role in the development o f these neoplasms. The ampli­
fication o f a restricted region o f 12p in primary TGCT confirms and extends our previous observations 
and, as such, represents an important step forward in the identification o f gene(s) on 12p relevant for 
the pathogenesis o f these tumors.
INTRODUCTION
The most common cancer in the caucasian young adult 
male population is the germ cell tumor of the testis 
(TGCT) [1, for review]. Because its incidence is still 
increasing, and effective treatment in its preinvasive stage 
is possible [2], understanding of the mechanisms involved 
in the etiology of this neoplasm may have important 
implications for the development of early detection strate-
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gies. In spite of its technical limitations in the study of 
solid tumors in general, karyotyping has been highly infor­
mative in the detection of chromosomal aberrations in 
TGCT [3-5]. In accordance with results of total DNA con­
tent analysis [6, 7], TGCT are found to be aneuploid, 
around the triploid range. Besides consistent over- and 
underrepresentations of some (parts of) chromosomes, the 
only recurrent structural abnormality is the isochromo­
some 12p [i(12p]] [5], first reported in TGCT by Atkin and 
Baker in 1983 [8]. This anomaly is found less frequently in 
seminomas (SE), composed of malignant counterparts of 
early germ cells, than in nonseminomatous TGCT (NS), 
which are caricatures of early embryonal development 
composed of embryonal (embryonal carcinoma (EC] and 
teratoma (TE)) and/or extraembryonal (yolk sac (YS) and 
choriocarcinoma (CH)) components [9, 10], Fluorescence 
in situ hybridization (FISH) using region-specific probes 
showed that also i(l2p)-negative TGCT invariably exhibit 
overrepresentations of 12p-sequences [11, 12], Because 
conventional cytogenetic information is derived from 
mitotic cells, such data may be biased due to selection of
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subpopulations of cells by the methods of direct harvest­
ing or short-term in vitro culture. This has recently been 
suggested for SE with respect to the presence of i(12p) 
[13]. Also the presence of markers of which, by definition, 
the chromosomal origin can not be determined, may ham­
per the identification of certain chromosomal regions 
important for the development of this cancer.
Comparative genomic hybridization (CGH) allows the 
detection of DNA copy number changes in relatively small 
amounts of tumor DNA [14]. Because no metaphase spreads 
are required CGH can be applied regardless of mitotic ac­
tivity, thereby excluding in vivo or in vitro selection. In 
addition, CGH offers the possibility of revealing regions of 
amplification or deletion that are not identifiable via kary­
otyping.
We analyzed a series of 15 primary TGCT (including 
both  SE and NS) and two metastatic residual tumors after 
chemotherapeutic treatment using both karyotyping and 
CGH. The metaphase spreads were isolated via direct har­
vesting of the SE and after short-term in vitro culture of 
the NS. Similarities and differences in the chromosomal con­
stitution of the various tumor samples as detected by both 
techniques are evaluated.
MATERIALS AND METHODS 
Patient samples
Fifteen  TGCTs collected from collaborating hospitals in 
t l ie  Western part of the Netherlands were used in this 
study. The tumors were classified according to the World 
H ea lth  Organization (WHO) recommendations [9], as de­
scribed [6], and identified as six SE, seven NS, and two 
combined tumors (CT) [15]. The tumors were surgically re­
m oved before the patient was treated with chemotherapy 
and /o r irradiation. In addition, two metastatic residual tu­
mors, one mature TE (2101) and one EC (5695), were stud­
ied . Representative parts of tumor component(s) were 
snap  frozen in liquid nitrogen (for DNA isolation) and 
fixed in 4% buffered formalin for paraffin embedding (for 
histological classification).
Slide Preparation and Karyotyping
Metaphase spreads of SE and NS were prepared according 
to standard procedures. Briefly, the mitotic cells of the SE 
were, after mechanical dissociation of the tumor, directly 
harvested in the presence of Colcemid (Life Technologies, 
N ew  York, USA). The cells were subsequently swollen in 
hypotonic KC1 solution and fixed with methanol-acetic 
acid (3:1). The NS were enzymatically digested using col- 
lagenase and cultured in vitro for a few days, after which 
they  were treated as reported before [16, 17].
For karyotyping, air-dried preparations were banded 
using pancreatin (Sigma, St. Louis, USA) as reported [18]. 
The chromosomal constitutions were described according 
to the recommendations of the ISCN 1991 [19], and calcu­
lated on the basis of a triploid DNA content, to stress the 
over- and underrepresentations of (parts of) chromosomes 
relative to the triploid situation. Although the NS were 
randomly selected, five i(12p)-negative SE were chosen for 
this survey (see Table 1). Such tumors may be instrumen­
tal in the delineation of the critical region of overrepresen­
tation of the short arm of chromosome 12, as was suggested 
recently through the analysis of a metastasis of a SE [12].
Comparative Genomic Hybridization and Interpretation
For CGH, metaphase spreads were prepared using stan­
dard procedures (see above) from in vitro phytohemagglu­
tinin-stimulated peripheral blood lymphocyte cultures of 
a healthy male (46,XY). High molecular weight DNA of the 
tumor as well as control DNAs (from peripheral blood 
cells of healthy males), were isolated using standard pro­
cedures [20], CGH was performed as described before [12, 
21-23]. To exclude false positive and false negative obser­
vations, DNAs obtained from 10 healthy individuals were 
analyzed as described for the tumors. Regions that showed 
variations in centromeric and heterochromatic regions, 
p-arms of acrocentric chromosomes and telomeric regions, 
were omitted from analysis.
For each hybridization, 400 ng digoxigenin (11-dUTP 
[Boehringer Mannheim, GR]) labeled tumor DNA and a 
similar amount of biotinylated (14-dATP [GIBCO-BRL]) 
control DNA were used. Eighty (jLg of COT-1 DNA (Life 
Technologies) was added as competitor DNA to reduce 
background signal due to repetitive sequences. After 2-4 
days of incubation under a coverslip in a moist chamber at 
37°C, the slides were washed according to regular FISH 
protocols [24], Visualization of the hybridized DNAs was 
achieved with fluorescein isothiocyanate (FITC) conju­
gated sheep-anti-digoxigenin (Boehringer) and pentame- 
thine cyanine dye isothiocyanate (CY3) conjugated avidin 
(Jacksons ImmunoResearch Laboratories, West Grove, 
USA). The results were evaluated using a Zeiss Axiophot 
epifiuorescence microscope, equipped w ith  a Photomet­
ries high-performance CH250/A cooled CCD-camera (Pho­
tometries, Tucson, AZ) interfaced onto a Macintosh 
Quadra 950 computer using the comparative genomic hy­
bridization applications w ithin the Oncor-Image FISH 
software package (Qncor, Gaithersburg, MD). These appli­
cations allow a pseudocolor reproduction of fluorescence 
ratios of CY3 (reference DNA) and fluorescein (tumor 
DNA).
All TGCTs were analyzed assuming no host cell con­
tamination, Le,, instrument setting of 100% tumor. Because 
SE are known to contain variable amounts of infiltrating 
lymphocytes [9], these were also analyzed assuming 50% 
host cells [25], For each tumor, five metaphase spreads, 
with similar imbalances on both chromatids, were inter­
preted according to previously published criteria [22, 23, 
26]. Digital analysis allowed representation of the results 
as fluorescence intensity profiles for each fluorochrome 
along the chromosome. Photographic images were made 
using a Tektronics SDXII color dye sublimation printer.
RESULTS
The cytogenetic data of the primary TGCTs and the resid­
ual tumors are summarized in Table 1 as modal represen­
tative karyotypes. All showed an aneuploid DNA content 
around the triploid range with multiple numerical and 
structural aberrations. The modal number of short and long
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Table 1 Modal representative karyotypes of the testicular germ cell tumors of adolescents and adults (TGCTs), based on
a triploid DNA content (the aberrations also detected by a comparative genomic hybridization are underlined)
Histology
Seminoma
Nonseminoma
Combined TGCTs 
Seminoma
S e m in o m a
Residual Tumors
Case Chromosomal Constitution
4255
1665
5718
5731
7214
2655
239
3035
5116
6537
8007
1862
2871
2207
3284
2101
5695
68-76,XXY,addil)fql2l,+dicil:12)fpl3;q22),-5,+?del(6Xq21q23), + 7, + 8 ,+ 8 , - 1 3 , + 14, + 1 5 - 1 8 ,  
+ 21 ,~22 ,+1—7m ar[cpll]
57-59,X,der(X)del(XXp22)t(X;12)(q23;ql2) ,-Y,add(l)(q24), + add (l)(p l3 ) ,-2 ,d ic (3 ;22 X p ll;p ll) ,  
ÍÍ3]fpl0l, + i f 3 i f q l Q ] 4,dic(4;13]fq35;pl2) , - 5 , - 7 , + 8 , - 9 , — 10 ,- l l ,a d d ( l2 ) (q 2 4 . l ) ,  + i(l2)(plO),
-13 ,-13 ,d ic(13;19)(p ll;q ll) ,-15 ,der(15)t(15;15)(p l3 ;q ll) ,-16 ,-17 ,-18 ,der(20]t(l;2 ;20;?) 
(q25q44;q32;ql2;?]f-21,add(21)(pl2),der(2l)t(21;21)(pl2;qll.l),der(22)t(7;22)(qll;pl2),+m arl, 
+ m ar2, + mar3,+1 -  3mar [ cp 7 ]
69—74,XXY,der(l)t(l;16)(pl2;pll.2),add(3)(q24)J- 4 , - 5 ,  + del(7)(pl2), + der(8)t(8;12)(qlQ;pll)x2, 
-9,add(9)(q34),der(9}t(3;9)(ql3;p24) -11,-+12 .-13 ,--15J- 1 7 iadd(17)(p ll .2 )J- 1 8 ladd(18)(q22)J 
add(19Hpl3.2],+21,+21, + 21, + 22,+der(?)t(?;12)(?;pll)I+ m a r l ,+ 0 -2 m a r[c p l0 ]
71-B2,XXY,+l, + 2 ,it4](q l0),-5 ,+6 ,+7, + 8, + add(12X pll) ,-13 , + l4 , + 15,+19,-2Q,+21, + 21,+22, 
+ m a r l , +1 -  6mar[cp9]
55-69,XXY(+addil)(p22],der(2)t(2;maTlXq37;?),add(3)(p24),der(3)t(3;9)(p24;ql2),add(4Xq32), 
der(4)i(4)(ql0)add(4)(q35),+i(4)(ql0),-5,add(6Hql6)del(6)(p23),+add(6)(q27), + add(7)(pll),
— 9 ,-1 0 ,  —11,add(llHq23), + 12,+add(12Hpll),- 1 3 ,+14, + 15,add(16Xq21), —17, —1 8 ,-1 8 ,-2 0 ,
+ 21,+add(21)(pl2),+marl,+niar2,+mar3,+mar4, + l-G m ar[cp l0 ]
69—71.XX,—Y,+der (X)t(X;14)(q22;qll), + 2, + der(3)t(l;3)(qllq27), + der(4]t(4;12;?;15](q21;
ql5q22;?;ql3),—5,der(5)t(5;?;16)(pl5.3;?;qll), + der(7)t(7;?;10)(qll.2;?;qll))+8,+8,add(9](p22)l 
-1 1 ,  ad d ( l l) (p l5 ) ,add(12](pl3),add(12](pl3), + der(12)t(12;?;15)(q22;?;ql3], —13,-14 , —15, 
- 1 6 , - 1 7 ,  der (17)t(7;?;17][pl3;?;q25),-18,der(2Q)t(14;2Q)(qll;pll), + 21> + 21, + 22 [cp5]/69-71, 
idem ,“ l,+add(l)(q32),-8 ,+ i(8)(ql0) [cp4]
62—64.XY,—X ,+del(l)(p34),-4 ,—5,add(5)(q35), + del(6)(q21], + 8> —9, —10, —l l ,  + i(12)(pl0), —13,
—17,—18,—22,+0-Smar [cp2]
52-56,XXY,addd)(qll), + der(l) t( l;2K ql0 ;p l0],-2 ,add(3)(p l2),-4 j- 5 , - 6 , i(7)(pl0),-9,del(9) 
(q ll) ,  —1 0 , - 1 1,der(ll)t(9 ;ll;ll)(q l3;ql3q25;q25),-1 3 ,add(13)(q2l)t+ ad d (1 4 )(p l2 ) ,-1 5 ,-1 6 t 
-1 8 ,  - 1 9 , - 2 0 , - 2 1 , - 2 1 , - 2 1 , - 2 2 , - 2 2 , +m arl,+m ar2, + l -4 m a r  [cplO]
68-74,XXY,tas(l;9)ip36;q34),del(6)[ql3ql4),+ 8 ,-9 , tas(9;17)(q34;q25)+i(12)[plQ)x2,+ 14,-17, 
-18 ,add (18)[p ll ,3 ) ,-22 , + 0-3mar [cplO]
64-66,XXf-Y ,add[l)(p32)ladd{l)(q31)J+add[3)(pl4),- 5 , +  7 , - 1 0 , - 1 1 ,+ add(l2 )(q ll) ,
?i(12)[plQ)x2,- 1 3 , - 1 4 , add[15)(q24),-1 9 ,2 0 ,-2 1 ,-2 2 ,+ 3 -6 m a r  [cp4]
53-61,X,add(X)(qll),Y,add(l)(p36]- 2 , add(3)[p21)3- 4 , - 5 , -6 ,add(9)(q21),- 1 0 , - 1 1 , + i(12](pl0), 
- 1 3 , - 1 5 , - 1 8 , - 1 9 , - 2 1 , - 2 2 , - 2 2 , +der[7)t(7 ;?jl2)(pll;? ;p ll),+m arl,+m ar2, + 3-12mar [cp8]
61—67.XX," Y .-4 . + 7,—9,-10 , —I l , add(ll) (q l3 )t+i(12)ipl0)x2,-1 3 ,  —14, —18,add(19)íql3],+add 
(19}(ql3),-22 ,+m arl [cp8]
56-61>XXY,add[l)(p21),-4,-5,ins(5;?)(qll;?l,add(6)(q24), + 8, —9 , - 9 , - 9 ,  —1 0 , - 1 1 , - 1 1 , - 1 3 , - 1 4 ,  
add(14)(pl2),der(16)t[9;16)(p21;pl2],-18,—22,+der(?)t(?;7)(?;pl3), + der(?)(ll;?;12)(ql2,l;?;pll)l
+ m a r l ,+ 0-1 mar [cplO]
60-64.XX.-Y  )- 3 , z 4,™ 5,add(6)(p22),+add(7)(q22),der(8)t(8;12)(pll.2;pll.2),-9,-ll,add(ll] 
[pl2),add(12)(pl2),—13,—1 4 ,-1 6 ,-1 7 ,-1 8 ,+ 2 1 ,  + 21)+ m arl ,+ m ar2 ,+ m ar3 , + 0-lmar[cp7l/ 
60-62,der(X)t(X;l)[q21;ql2)-Y,add(3)[p24),- 4 , - 5 , - 6 ,  + i(8)[ql0),- 9 , - 9 , - 1 1 , - 1 1 , + add(12) 
[ql4), —1 3 ,-1 6 ,-1 7 ,  —17,—18,add(20)(ql2), + 21,+22,+ r ,+ m a r l ,  + 0—3mar [cp3] 
66-67,X,add(X)[q28),-Y,add(l) (qll),add(l](q43),+_2,-4,-5,add(5){pl5)) —6,-6,ins(6;?)(qll;?)f 
+ 7, + 8 ,~9 ,id ic(9)(p24),-ll ,  + 12,-13, + 15,dicil7;?i21)(pll.2;?ipl2], + deri211tf6;21)ipll;pl2),
add(22)(pl2), + m arl [cp9]
59—62,XXY,del(l)(p35), —2.add(3)(pl2),—4,—5,+del(8)(pll), —9, — 10,add(10)(q22), —11, —13, —14, 
—15, —18,—19>der(20)t(12;20)(pll;pll),+21,—22,+m arl,+m ar2  [cplO]
57-64,XXY,+Y,add(2)(q24),t[3;15)Cp23;q24),-4,dic(4;ll)(pl6;pll,2)," 5 ,add(6)(ql3), + 8, - 9 , - 1 0 ,  
- 1 1 , - 1 1 , i(12)(pl0)t+i(12](pl0),- 1 3 , - 1 4 , - 1 5 , - 1 5 , - 1 6 , - 1 8 , add(l9Kql3.1), + der(21)til2;21)
(p 11 ;p 11),+ m a r l ,+ mar2,+ mar3,+ mar4, + 0-2mar [cp7]/62-63,idemJ + add(4)(pl6), + l l  [cp3]
arms (if involving more that 50% of its length and account­
ing for only the long arms of acrocentric chromosomes as 
described by De Jong et al. [3]) for each chromosome was 
determined. These data, depicted in Figure 1, indicate a 
similar pattern of chromosomal over- and underrepresen­
tation in SE and NS, i.e., underrepresentation of (parts of) 
chromosomes 4, 5, 9, 11, 13, and 18, and overrepresenta­
tion of (parts of) chromosomes 7, 8, 12, and X.
The aberrations found by CGH are illustrated in Table 2 
and Figure 2 (only the results obtained from analysis of SE
CGH of Testicular Germ Cell Tumors 149
8
7
a
g 6  
u
u-o
os ü
S
D
25 4
3
2
1
8
7
6
5
4
3
2
1
i i" i i i i i i i ' i i i i i i i T—i—i—r
SEMINOMAS
1 i i I ! i I I m.
1 2  3 4 6 0 7 8 9 10 11 12 13 1-4 16 i e 17 1B 10 20 21 22 X y
r~i i r~i i i i i—i—i—i—i—i—i—i—i—i—i—i—i—i—i—r 
NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS
JU
nn
iLLi
n
iiii ilJ
1 2 0 4 6 Ö 7 B 0 10 12 13 14 1fi 18 17 10 1Û 20 21 22 X  y
CHROMOSOMES
Figure 1 Schematic representation of the average copy number 
per chromosome for six seminomas and seven nonseminomatous 
testicular germ cell tumors of adolescents and adults, calculated 
on the basis of karyotypic results as reported before [3],
with instrument settings assuming 50% host cells are 
shown). Those aberrations that were also detected (partly) 
with karyotyping are underlined in Table 1. Within the 
group of the six primary SE, gain was found 14 times in­
volving six different chromosomes, and loss six times involv­
ing three different chromosomes. For the NS (n = 7), gain 
was found 10 times affecting four different chromosomes 
and loss five times affecting four different chromosomes. 
No imbalances were detected by CGH for chromosomes 1, 
16, 17, 20, 21, 22, and Y (these are excluded from Figure 
2), whereas aberrations (of parts) of chromosomes 2, 5, 9,
18, and 19 were only found in a single primary tumor. The 
following regions showed aberrations in multiple cases: 
loss of parts of chromosome 4 (in one SE, one NS, and one 
SE of a CT), 11 (in one NS and a SE of a GT), and 13 (in 
three SE, one NS, and one SE of a CT), gain of parts of 
chromosome 7 (in three SE, one NS, and one NS of a CT), 
8 (in three SE, one NS, and one NS of a CT), complete 12p 
(in three SE, six NS, and one NS of a CT), region 12pll.l- 
pl2.1 (in one NS and both components of one CT) and X 
(in three SE and one NS). Some aberrations found in SE 
were only identified using the instrument settings assum­
ing 50% tumor, i.e., loss of 13q31-qter in tumor 4255 and 
13 in tumor 2655, and gain of 8qter in tumor 1665, 7qll in 
tumor 5718, and 7, X in tumor 5731.
Although only the SE components of the CTs could be 
karyotyped (Table 1), both histological components were 
studied by CGH (Table 2), Gain of 12pll.l-pl2.1 was de­
tected in both components of tumor 2207 (illustrated in 
Figure 3). The ratio value of the amplicon was approxi­
mately three times higher in the SE compared to the NS 
(not shown). Other aberrations were found either in the SE 
or NS component within that CT. The other CT (3284) 
showed only gain of 12p in the NS component by CGH. 
The residual tumors showed four times gain, affected two 
different chromosomes, and five times loss affecting four 
different chromosomes. Both cases showed loss of part of 
the long arm of chromosome 6 (encompassing ql5-q21) 
and gain of the complete short arm of chromosome 12.
Although most aberrations found by CGH were con­
firmed by karyotyping, others were unexpected, i.e., over- 
representation of region 9q21~q31 in 4255, 8qll.l-ql2, and 
12pll.l-pl2.1 in 3035.
DISCUSSION
The series of six SE and seven NS presented here, shows a 
pattern of over- and underrepresentation of (parts) of chro­
mosomes as found in a group of more than 100 TGCTs 
published before [5]. The recently developed technique of 
comparative genomic hybridization (CGIi), a bicolor FISH- 
approach that enables detection of relative over- and 
underrepresentation of chromosomal regions [14], turned 
out to be very useful in the detection and mapping of 
DNA-sequence copy number changes in solid tumors [12, 
14, 21-23, 27-35]. We applied this technique to a series of 
karyotyped TGCTs to screen for chromosomal regions 
showing imbalances in these tumors possibly unidentified 
by conventional chromosomal analysis,
Multiple cases showed gain of (parts of) chromosome 7, 
8, X, and the short arm of chromosome 12, and loss of 
(parts of) chromosome 13 both by karyotyping and CGH. 
Although other losses or gains of some chromosomal re­
gions were expected from karyotypic analysis, these were 
not detected by CGH. This may be partly due to the pres­
ence of chromosomal segments hidden in markers, tumor 
heterogeneity, the sensitivity of the CGH applied, as well 
as the presence of host cells in the samples (illustrated by 
the results in SE). However, some unexpected copy num­
ber changes were detected by CGH in our series of TGCTs. 
These changes mostly involved small chromosomal re-
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Table 2 Gains and losses of chromosomal regions in testicular germ cell tumors of adolescents and
adults detected by comparative genomic hybridization
Histology Case Loss Gains
Seminoma
4255 13q31-qter 8, 9q21~q32
1665 8qter, 12p
5718 12p, X, 7qll
5731 13 7, 8q, X
7214 4p, 4ql3~qter 4ql2
2655 13, 18 7qll, 12p,X
Nonseminoma
239 12p
3035 7p, 8ql0-ql2, 12pll.l-pl2.1
5116 12p
6537 19 12p
8007 12p
1862 4q, llq22~qter 12p
2871 13 12p, X
Combined tumors
Seminoma
2207 4q,13q 12p ll.l—pl2.1
3284 llql3-qter 2q35-qter, 6pl0~p21.2
Nonseminoma
2207 7qll-q21, 8q21-q23, 12pll.l-pl2.1
3284 12p
Residual tumors
2101 6ql5-q21 12p
5695 5,6q, 12q21~q22, 13q 8p,12p
gions not detected with conventional karyotyping. In ad­
dition, CGH enabled us to determine the minimal regions 
of overlap of parts of chromosomes showing imbalances, 
i.e., 7qll and 13q31~qter. These results are in line with 
CGH data of a paraffin embedded SE obtained after univer­
sal DNA amplification [36]. Consistent with karyotypic 
analysis of a large series of TGCTs ([5] and this paper), 
overrepresentation of 12p is the most frequent aberration 
found. Interestingly, CGH revealed in two i(12p)-negative 
tumors (one SE and both components of a CT) specific am­
plification of a subregion of the short arm of chromosome 
121 i.e., 12p ll.l—p i2.1. Although this same region was re­
cently found to be amplified in a metastasis of a testicular 
SE [12], we now report that this anomaly may also be en­
countered in primary TGCTs. A very similar observation 
was recently made in three additional primary TGCTs (M. 
Korn, personal communication).
Because karyotyping of both the SE and NS compo­
nents of CTs is hard to achieve, CGH was used to compare 
their chromosomal constitutions. The results obtained il­
lustrate thattheSEandNS components of both cases stud­
ied here were at least partially genetically distinct. The 
only common aberration was the amplification of 12pll.l- 
pl2.1 in both components of one CT. However, the ratio 
value in the SE was approximately three times higher than 
in the NS. As we recently suggested [37] these results indi­
cate the SE and NS components of CTs might be mono­
clonal or biclonal in origin.
Figure 2 Schematic representation of relative loss (indicated 
on the left side of the chromosome) and gain (indicated on the 
right side of the chromosome) of chromosomal regions, detected 
by comparative genomic hybridization in six seminomas (marked 
by lines), seven nonseminomatous testicular germ cell tumors of 
adolescents and adults (marked by dotted lines), both compo­
nents of the combined tumors (illustrated as the pure SE and NS), 
and two metastatic residual tumors (also indicated by dotted 
lines).
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Figure 3 Example of the result of comparative genomic hybridization on chromosome 12 of the seminoma component of combined 
tumor 2207, showing tumor specific amplification (represented as relative overrepresentation of the green compared to the red signal), 
encompassing region 12pll.l-pl2.1. The blue line represents the ratio profile, i.e., the red to green fluorescence intensities over the 
whole chromosome length.
Another interesting finding with CGH is the specific 
loss of 6q-sequences (involving ql5-q21) in both residual 
tumors. This suggests that loss of gene(s) localized in this 
region may be involved in resistance to chemotherapeutic 
treatment, as recently suggested for glioblastoma multi­
forme [38]. Obviously, more data are required to substanti­
ate this notion.
In conclusion, our study of CGH on a limited number of 
TGCTs largely confirms our karyotypic findings on a series 
of more than 100 tumors [5]: overrepresentation of (parts 
of) chromosomes 7,8,12, and X, and underrepresentation 
of chromosome 13. In addition, through CGH the most 
likely regions involved could be identified, i.e., 7qll and 
13q31-qter. The most intriguing finding, however, is the 
amplification of a restricted region of the short arm of chro­
mosome 12, 12pll.l-pl2,l, in different primary TGCTs. 
Analysis of more TGCTs using this approach will bring the 
isolation of the relevant gene(s) on 12p in the realm of fea­
sibility.
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